Advances in technology sharpen diagnostics.
For example, earlier this month, Bayer Diabetes Care launched A1CNow SelfCheck, an A1C monitor that enables people with diabetes to check AIC levels at home. Measurement of AIC provides an average assessment of blood sugar levels over the past three months and is an indicator of how well diabetes is being managed.
According to Bayer, the monitor enables patients to watch their A1C levels more closely between health care provider visits, so that they can modify their diet and exercise or have a more informed discussion with their health care provider based on the results. The unit is said to provide at-home results within five minutes and deliver laboratory accuracy, and has an easy-to-use design.
At a health care provider's office patients can be tested with Bayer's A1CNow+ monitor, which provides results within five minutes, enabling physicians to evaluate their patients' overall diabetes control and discuss lifestyle and treatment modifications during the appointment rather than waiting for lab results a few days later. A1CNow SelfCbeck is said to complement the health care provider--administered A1C test but is not intended to replace it or routine blood glucose testing.
Bayer notes that A1CNow Self-Check, when used in conjunction with its Contour or Breeze 2 blood glucose meters, may help patients achieve tighter control in managing their diabetes, potentially reducing longer-term complications.
"Bayer's A1CNow SelfCheck provides patients with a new way to partner with their health are providers to better achieve good blood sugar control on both a daily basis and over the long term," notes Bayer Diabetes Care president Sandra Peterson.
Meanwhile, Home Diagnostics Inc.'s TRUE2go, billed as the world's smallest blood glucose meter, has received a Medical Design Excellence Award
(MDEA). The MDEA competition is described as a program that recognizes the achievements of medical product manufacturers responsible for groundbreaking innovations that are changing the face of health care. Small enough to twist and attach to the top of a vial of test strips, TRUE2go is said to deliver precise results in as little as four seconds using only 0.5 microliters of blood. TRUE2go uses the new TRUEtest platform of blood glucose test strips featuring patent-pending, state-of-the-art GoldSensor laser accuracy and the TRUEfill beveled tip, which is designed to ensure highly accurate test results and first test success.
"The Medical Design Excellence Award for TRUE2go is a testament to the dedication of the Home Diagnostics team for creating products that deliver outstanding performance and value while helping people with diabetes manage their disease in a way that fits their individual lifestyles," comments Home Diagnostics president and chief executive officer Joe Capper.
Roche Holding AG, the maker of Accu-Chek blood glucose monitoring systems and insulin pumps, recently rolled out two new tools that it says can help patients pinpoint food and lifestyle choices that have the biggest impact on their blood glucose levels, giving them greater control in their everyday battles against diabetes.
The company has debuted AccuChek Testing in Pairs and Accu-Chek 360-degree View tools as a way to help patients of all agesmanage their diabetes more easily and more effectively. The initiative is part of Roche's Behavior Change Through Patient Engagement program.
|Printer friendly Cite/link Email Feedback|
|Title Annotation:||RX RETAIL PHARMACY: Diabetes Care|
|Comment:||Advances in technology sharpen diagnostics.(RX RETAIL PHARMACY: Diabetes Care)|
|Publication:||Chain Drug Review|
|Date:||Jun 29, 2009|
|Previous Article:||Supplier stresses test affordability.|
|Next Article:||Program tackles cost of care.|